Sai Parenteral's Ltd.
•₹ 540.85-0.47%
2026-08-21
PROS
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.46x)
- Company maintains a comfortable, low leverage position
CONS
- A large part of profit comes from other income (25.8% of PBT)
- Working capital days have increased from 56 to 707 days
- Total debt has risen sharply - up 85.5% year on year
- Inventory has been piling up - inventory days up from 58 to 96
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SAIPARENT | 540.25 | 167.39 | 2386.78 | 0.00 | 79.23 | — | 1786.72 | — | 7.03 | 13.16 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| 19 | 57 | 53 | |
| 19 | 44 | 44 | |
| Operating Profit | — | — | — |
| OPM % | — | — | — |
| Other Income | 1 | 0 | 3 |
| Interest | 2 | 3 | 4 |
| Depreciation | 1 | 2 | 1 |
| 1 | 8 | 12 | |
| Tax % | 30.79% | -18.31% | 24.98% |
| Net Profit | 1 | 10 | 9 |
| 0 | 3 | 0 | |
| Equity Capital | 13 | 22 | 22 |
| Reserves | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% |
| Equity Capital | 13 | 22 | 22 |
| Reserves | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% |
Jun 2025
- 19
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 1
- 1
- Tax %
- 30.79%
- Net Profit
- 1
- 0
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 13
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 57
- 44
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 3
- Depreciation
- 2
- 8
- Tax %
- -18.31%
- Net Profit
- 10
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 53
- 44
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 4
- Depreciation
- 1
- 12
- Tax %
- 24.98%
- Net Profit
- 9
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| 97 | 124 | 162 | |
| 78 | 97 | 134 | |
| Operating Profit | 19 | 27 | 33 |
| OPM % | 19 | 22 | 21 |
| Other Income | 0 | 0 | 5 |
| Interest | 6 | 7 | 9 |
| Depreciation | 6 | 5 | 6 |
| 7 | 14 | 19 | |
| Tax % | 37 | 28 | 11 |
| Net Profit | 5 | 10 | 17 |
| EPS | 6 | 4 | 4 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 3 | 4 | 4 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 3 | 4 | 4 |
Mar 2023
- 97
- 78
- Operating Profit
- 19
- OPM %
- 19
- Other Income
- 0
- Interest
- 6
- Depreciation
- 6
- 7
- Tax %
- 37
- Net Profit
- 5
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2025
- 124
- 97
- Operating Profit
- 27
- OPM %
- 22
- Other Income
- 0
- Interest
- 7
- Depreciation
- 5
- 14
- Tax %
- 28
- Net Profit
- 10
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2026
- 162
- 134
- Operating Profit
- 33
- OPM %
- 21
- Other Income
- 5
- Interest
- 9
- Depreciation
- 6
- 19
- Tax %
- 11
- Net Profit
- 17
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 12%
- Last Year:
- 6%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 7 | 13 | 22 |
| 24 | 78 | 465 | |
| 43 | 53 | 85 | |
| Trade Payables | 22 | 32 | 26 |
| 37 | 39 | 206 | |
| Total Liabilities | 134 | 215 | 803 |
| ASSETS | - | - | - |
| 44 | 40 | 43 | |
| Capital Work in Progress | 2 | 0 | 1 |
| 0 | 28 | 158 | |
| 13 | 26 | 60 | |
| 0 | 86 | 81 | |
| Cash & Bank | 2 | 1 | 410 |
| 73 | 32 | 50 | |
| Total Assets | 134 | 215 | 803 |
| Total Debt | 69 | 72 | 133 |
| Net Working Capital | 9 | 19 | 314 |
| Contingent Liabilities | 2 | 2 | 2 |
| Book Value per Share | 44.02 | 0.00 | 0.00 |
| Face Value | 10.00 | 5.00 | 5.00 |
| Total Debt | 69 | 72 | 133 |
| Net Working Capital | 9 | 19 | 314 |
| Contingent Liabilities | 2 | 2 | 2 |
| Book Value per Share | 44.02 | 0.00 | 0.00 |
| Face Value | 10.00 | 5.00 | 5.00 |
Mar 2023
- Equity Capital
- 7
- 24
- 43
- Trade Payables
- 22
- 37
- Total Liabilities
- 134
- 44
- Capital Work in Progress
- 2
- 0
- 13
- 0
- Cash & Bank
- 2
- 73
- Total Assets
- 134
- Total Debt
- 69
- Net Working Capital
- 9
- Contingent Liabilities
- 2
- Book Value per Share
- 44.02
- Face Value
- 10.00
- Total Debt
- 69
- Net Working Capital
- 9
- Contingent Liabilities
- 2
- Book Value per Share
- 44.02
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 13
- 78
- 53
- Trade Payables
- 32
- 39
- Total Liabilities
- 215
- 40
- Capital Work in Progress
- 0
- 28
- 26
- 86
- Cash & Bank
- 1
- 32
- Total Assets
- 215
- Total Debt
- 72
- Net Working Capital
- 19
- Contingent Liabilities
- 2
- Book Value per Share
- 0.00
- Face Value
- 5.00
- Total Debt
- 72
- Net Working Capital
- 19
- Contingent Liabilities
- 2
- Book Value per Share
- 0.00
- Face Value
- 5.00
Mar 2026
- Equity Capital
- 22
- 465
- 85
- Trade Payables
- 26
- 206
- Total Liabilities
- 803
- 43
- Capital Work in Progress
- 1
- 158
- 60
- 81
- Cash & Bank
- 410
- 50
- Total Assets
- 803
- Total Debt
- 133
- Net Working Capital
- 314
- Contingent Liabilities
- 2
- Book Value per Share
- 0.00
- Face Value
- 5.00
- Total Debt
- 133
- Net Working Capital
- 314
- Contingent Liabilities
- 2
- Book Value per Share
- 0.00
- Face Value
- 5.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| -21 | 19 | 112 | |
| Cash from Investing | -17 | -13 | -136 |
| Cash from Financing | 30 | -6 | 433 |
| -8 | -0 | 409 | |
| Free Cash Flow | -21 | 13 | 102 |
| OCF / Net Profit | -4.54 | 1.82 | 6.65 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | -4.54 | 1.82 | 6.65 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- -21
- Cash from Investing
- -17
- Cash from Financing
- 30
- -8
- Free Cash Flow
- -21
- OCF / Net Profit
- -4.54
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -4.54
- Cumulative 5-Year FCF
- 0
Mar 2025
- 19
- Cash from Investing
- -13
- Cash from Financing
- -6
- -0
- Free Cash Flow
- 13
- OCF / Net Profit
- 1.82
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.82
- Cumulative 5-Year FCF
- 0
Mar 2026
- 112
- Cash from Investing
- -136
- Cash from Financing
- 433
- 409
- Free Cash Flow
- 102
- OCF / Net Profit
- 6.65
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 6.65
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2023 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 6.41 | 3.86 | 3.80 |
| Book Value (₹) | 44.02 | 34.27 | 110.23 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 7.26 | 5.93 | 5.11 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 19.39% | 21.61% | 17.56% |
| Net Margin % | 4.74% | 8.27% | 10.34% |
| ROE % | 14.56% | 16.76% | 5.80% |
| ROCE % | 12.97% | 16.49% | 7.03% |
| 3.42% | 5.89% | 3.30% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 231 | 217 | 189 |
| Inventory Days | 50 | 58 | 96 |
| Payable Days | 140 | 135 | 101 |
| 140 | 139 | 184 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 2.18x | 0.79x | 0.27x |
| Interest Coverage (x) | 2.27x | 2.97x | 3.14x |
| 1.12x | 1.17x | 2.15x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 28.38% | 30.57% |
| Operating Profit Growth % | 0.00% | 44.75% | 22.64% |
| Net Profit Growth % | 0.00% | 124.30% | 63.15% |
| 0.00% | -39.74% | -1.70% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 3.09x | -7.65x |
Mar 2023
- EPS (₹)
- 6.41
- Book Value (₹)
- 44.02
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.26
- Operating Margin %
- 19.39%
- Net Margin %
- 4.74%
- ROE %
- 14.56%
- ROCE %
- 12.97%
- 3.42%
- Debtor Days
- 231
- Inventory Days
- 50
- Payable Days
- 140
- 140
- Debt to Equity (x)
- 2.18x
- Interest Coverage (x)
- 2.27x
- 1.12x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2025
- EPS (₹)
- 3.86
- Book Value (₹)
- 34.27
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.93
- Operating Margin %
- 21.61%
- Net Margin %
- 8.27%
- ROE %
- 16.76%
- ROCE %
- 16.49%
- 5.89%
- Debtor Days
- 217
- Inventory Days
- 58
- Payable Days
- 135
- 139
- Debt to Equity (x)
- 0.79x
- Interest Coverage (x)
- 2.97x
- 1.17x
- Revenue Growth %
- 28.38%
- Operating Profit Growth %
- 44.75%
- Net Profit Growth %
- 124.30%
- -39.74%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 3.09x
Mar 2026
- EPS (₹)
- 3.80
- Book Value (₹)
- 110.23
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.11
- Operating Margin %
- 17.56%
- Net Margin %
- 10.34%
- ROE %
- 5.80%
- ROCE %
- 7.03%
- 3.30%
- Debtor Days
- 189
- Inventory Days
- 96
- Payable Days
- 101
- 184
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 3.14x
- 2.15x
- Revenue Growth %
- 30.57%
- Operating Profit Growth %
- 22.64%
- Net Profit Growth %
- 63.15%
- -1.70%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -7.65x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-20 - Intimation-Newspaper Publication of Notice of 25" Annual General Meeting of the Company for the financial year 2025-26.
- Copy of Newspaper Publication
2026-08-20 - Submission of Newspaper Publication(s) in PAS-1 for change and variation in the objects of utilization of the Initial Public Offering ( IPO ) proceeds
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026